Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- GTX118134 - Provider product page
- Provider
- GeneTex
- Proper citation
- GeneTex Cat#GTX118134, RRID:AB_11169588
- Product name
- FSTL1 antibody [N1C3]
- Antibody type
- Polyclonal
- Reactivity
- Human
- Host
- Rabbit
Submitted references Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma.
Chiou J, Su CY, Jan YH, Yang CJ, Huang MS, Yu YL, Hsiao M
Scientific reports 2017 Aug 29;7(1):9830
Scientific reports 2017 Aug 29;7(1):9830
No comments: Submit comment
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Sample (30 ug of whole cell lysate) A: Jurkat 10% SDS PAGE GTX118134 diluted at 1:1000
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of paraffin-embedded human breast cancer, using FSTL1(GTX118134) antibody at 1:250 dilution.
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- FSTL1 antibody [N1C3] detects FSTL1 protein at cytosol on human breast carcinoma by immunohistochemical analysis. Sample: Paraffin-embedded human breast carcinoma. FSTL1 antibody [N1C3] (GTX118134) dilution: 1:250.Scale bar = 100 £gm.